Related Experiment Video
Updated: Aug 20, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Plasma lipids and stroke
1Department of Neurological Sciences, Center for Stroke Research, Rush Medical College and Rush Medical Center, Chicago, Illinois, USA.
Insights
High lipid levels are a known risk factor for heart disease, but their role in stroke causation is debated. Further research, including clinical trials on lipid-lowering for stroke prevention, is needed to clarify this connection.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Public Health
Background:
- High plasma lipid levels are a significant modifiable risk factor for coronary heart disease.
- The role of plasma lipids as a risk factor for stroke remains controversial and not well-established.
- Existing evidence links lipids to systemic arterial disease and suggests a potential role in stroke development.
Purpose of the Study:
- To discuss the ongoing controversy regarding plasma lipids as a risk factor for stroke.
- To highlight the need for further investigation into the relationship between lipids and stroke.
- To propose a clinical trial for primary stroke prevention through lipid lowering.
Main Methods:
- Review of pathophysiologic evidence linking lipids to systemic artery disease.
- Analysis of results from clinical trials on coronary heart disease prevention and lipid-lowering.
- Discussion of the current scientific debate on plasma lipids and stroke risk.
Main Results:
- Pathophysiologic data and coronary heart disease trial outcomes suggest lipids may contribute to stroke causation.
- Despite this, lipids are not yet established as a definitive risk factor for stroke.
- A clear understanding of lipids' role in stroke remains elusive.
Conclusions:
- Clinical trials targeting lipid-lowering for primary stroke prevention are warranted.
- Such trials would help resolve the plasma lipid-stroke controversy.
- This research is crucial for advancing stroke prevention strategies in the 21st century.
Abstract:
High plasma levels of lipids are an important modifiable risk factor for coronary heart disease, but are not established as a risk factor for stroke. Pathophysiologic evidence that links lipids to major systemic artery disease, and the results of clinical trials of coronary heart disease prevention in relation to lipid-lowering suggest that lipids may play an important role in the causation of stroke. We discuss the controversy concerning plasma lipids as a risk factor for stroke. A clinical trial targeted at lowering levels of lipids with the aim of primary stroke prevention would be a timely and important contribution. Armed with this information, we could further clarify the plasma lipid-stroke controversy and move into the 21st century with a better understanding of stroke prevention.
Related Concept Videos
Asymmetric Lipid Bilayer
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology

